Analytical 360 in the News
- 12/5/2013 – KIRO Radio – “Small Seattle lab could win big when recreational pot goes on sale”
- 11/13/2013 – Seattle Weekly – “Going To Pot”
- 10/16/2013 – TVW – “Inside A Marijuana Testing Lab: Interview with Analytical 360″
- 10/15/2013 – The Capitol Record – “Marijuana Testing Labs Await State Standards”
- 09/30/2013 – NPR – “Labs Worry As Marijuana Testing Standards Lag”
- 07/18/2013 – Associated Press – “Should states test marijuana for potency, purity and safety?”
- 05/17/2013 – The Seattle Times – “Pot rules taking shape; public gets a taste of what’s ahead”
- 04/26/2013 – NBC News – “Moldy marijuana? Legal markets spark push for health, safety standards”
- 04/24/2013 – The Stranger – “The State Says This Pot Isn’t Technically ‘Marijuana’”
- 04/24/2013 – Associated Press – “Officials: Legal marijuana law jeopardizes all pot prosecutions”
- 04/18/2013 – Associated Press – “VIDEO: For Wash. government bean-counter, a pot education”
- 04/18/2013 – Associated Press – “For Wash. government bean-counter, a pot education”
- 04/08/2013 – NPR – “For regulators, legalizing pot all about ‘getting into the weeds’”
- 03/06/2013 – Northwest Leaf – “Cannabis Testing”
- 02/20/2013 – Seattle Met Magazine – “Wait, How High Am I?”
- 02/08/2013 – KOMO 4 News – “No protection for medical marijuana users under new law”
Who We Are
Analytical 360′s dynamic team of biochemists, laboratory technicians, and friendly, courteous staff are dedicated to ensuring that patients using therapeutic cannabinoids have access to important information about the potency and safety of their medicine.
Using advanced equipment and well established published techniques, we provide dry-weight quantification, potency testing, cannibinoid profiling, foreign material detection and microbial bioburden screening. Analytical 360 safety-certifies medical cannabis for the protection, education and empowerment of patients.
We employ High Performance Liquid Chromatography (HPLC) technology to determine the original composition of cannabinoids present by direct analysis of plant and edible samples. This technique uniquely determines all of the medicinal components contained within the products and provides a cannibinoid profile in order to more accurately evaluate potency, institute material quality assurance and to identify plant phenotype.
Dr. Lara Taubner, (Chief Scientist) has over 20 years’ experience in academic and government laboratory environments, and has extensive experience with Organic Synthesis, TLS, HPLC, Mass Spectrometry, and Nuclear Magnetic Resonance. She is also proficient in the cloning, production, isolation, and high resolution characterization of bio-molecules. Dr. Taubner has been extensively published in peer-reviewed scientific journals and has been awarded the National Institute of Health Director’s Award for her work relating to Mad Cow Disease and research investigating the molecular interactions leading to amyloid diseases; which include Parkinson’s, CJD, Alzheimer’s and Diabetes. Lara finished a postdoctoral fellowship at the National Institute of Health, where she was part of a team that developed an assay to detect minute amounts of infectious materials that cause Mad Cow disease. Dr. Taubner holds a BS in Chemistry, an advanced PhD in Biophysics, and has received various awards and honors.
Randall Oliver, (Chief Scientist) holds a degree in Science and has over 20 years’ experience in the isolation and characterization of molecules, as well as extensive experience using filtration chromatography, light scattering, fluorescence, UV Spectroscopy, Mass Spectroscopy, and Crystallography. Randall has spent the majority of his career in the biotech and pharmaceutical industries, including Zymogenetics and GlaxoSmithKline, where he designed and implemented processes to analyze and produce biopharmaceuticals. Most recently he was part of a team that developed methods to manufacture and quantify adjuvants for next generation malaria and cancer vaccines. Randall is also an author in several peer reviewed journals.
Brenton Dawber, (Chief Executive Officer) holds a degree in business and has an extensive background in production and project management. Before relocating to the United States, Brenton managed family owned advertising businesses in South Africa. Prior to assembling the Analytical 360 team, Brenton served as a manager at a networking technician firm.
Edward Stremlow, (Chief Operating Officer) holds a degree in accounting and has an extensive history in facility and operations management. He served as General Manager at the Woodland Park Zoo in Seattle, and the Hogle Zoo in Salt Lake City, UT, and managed a sales and development team of North American Zoos and Aquariums. He is also experienced as a financial advisor, senior loan officer, and previously managed 2 appraisal firms prior to the formation of Analytical 360.
John Brown, (Chief Technology Officer) has 20 years’ experience as an IT professional, working with high profile companies in dot-com, telecommunications, financial, and security industries. He brings to Analytical 360 his vast expertise in data analysis, database development, software development, web development, system administration, network engineering, security, and scalability.
Analytical 360 Team
Caitlin Reece, Lab Manager; B.S., Chemistry, Evergreen State
Steven McNalley, Lab Technician; B.S., Organic Chemistry, Evergreen State
Cory Fry, Lab Technician; B.S., Chemistry, Evergreen State
Virginia Webber, Quality Control Manager; B.S., Herbal Sciences, Bastyr University
Timothy Henry, Account Manager/Field Tech; B.S., Environmental Science, Evergreen State
Mike Zabrek, Account Manager; B.A., University of South Florida
Bratley Stubblefield, Account Manager; B.A., Iowa State University
Jeffrey Clemens, IT Specialist; GMI Engineering and Management Inst. – Kettering University
Carlin DaRonche, IT Specialist
Patients using therapeutic cannabinoids in the Pacific Northwest deserve assurance that the herbal medicines recommended to them by doctors meet the same standard for effective, safe and reliable treatment as traditional pharmaceuticals.
By providing information on dosage, strain verification, and safety, Analytical 360™ strives to safeguard the health and wellbeing of these patients.
Equipment, Processes & Validation of Methods
Analytical 360 is a state-of-the-art Cannabis Analysis Laboratory equipped with cutting edge, High Performance Liquid Chromatography (HPLC) technology. This machinery enables our team of biochemists to measure the potency of samples with far superior precision and efficiency than gas chromatography.
We use HPLC methodology in line with laboratory standards and practices within the wider national and international medical cannabis community and acknowledge the obvious advantages that HPLC technology holds over gas chromatography for accurate cannabinoid profiling. We employ established practices in conjunction with tightly controlled scientific procedures to produce test results that are precise, can be replicated and are independently verifiable.
Our tests procedures are designed by biochemists and involve methodology developed through decades of research and experimentation in isolating and characterizing molecules from natural source materials.